Prevalence and cardiovascular risk assessment in HIV patients: comparison between SCORE2 and REGICOR scales

被引：0
|
作者：
Diaz Martin, Estefania [1 ]
Cachapa Viera, Ines [1 ]
Calzado Isbert, Sonia [2 ]
Navarro Saez, Maria Del Carmen [2 ]
Pedrosa Aragon, Marc [2 ]
Navarro Vilasaro, Marta [2 ]
机构：
[1] Hosp Univ Parc Tauli, Serv Med Interna, Barcelona, Spain
[2] Hosp Univ Parc Tauli, Serv Enfermedades Infecciosas, Barcelona, Spain
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2024年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P303
引用
收藏
页码：269 / 269
页数：1
相关论文
共 50 条
  • [41] Cardiovascular Risk in Systemic Lupus Erythematosus: Carotid Ultrasonography Is Useful for the Re-stratification of Cardiovascular Risk Determined by Score2
    Corrales Selaya, Cristina
    Bejerano, Carmen
    Secada Gomez, Carmen
    Portilla-Gonzalez, Virginia
    Blanco-Alonso, Ricardo
    Martinez Taboada, Victor Manuel
    Riancho, Leyre
    Corrales-Martinez, Alfonso
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3031 - 3033
  • [42] Predictive Value of the SCORE, SCORE2, and Pooled Cohort Risk Equation Systems in Patients with Hypertension
    Karakayali, Muammer
    Pusuroglu, Hamdi
    Altunova, Mehmet
    Yilmaz, Emre
    Gullu, Aysenur
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2023, 51 (06): : 407 - 414
  • [43] Incremental utility of circulating biomarkers for cardiovascular risk prediction beyond the updated SCORE2 model
    Lehmacher, J.
    Toprak, B.
    Gossling, A.
    Iacoviello, L.
    Thorand, B.
    Linneberg, A.
    Kuulasmaa, K.
    Ferrario, M. M.
    Soederberg, S.
    Palmieri, L.
    Koenig, W.
    Tunstall-Pedoe, H.
    Zeller, T.
    Blankenberg, S.
    Twerenbold, R.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2262 - 2262
  • [44] How the new ESC cardiovascular risk chart, SCORE2, identifies additional high risk patients in a population free of cardiovascular disease with large waist circumference
    Douhard, Sarah
    Snel, Marc
    Van Gaal, Luc
    Brohet, Christian
    Scheen, Andre
    Demeure, Fabian
    Descamps, Olivier S.
    ACTA CLINICA BELGICA, 2022, 77 : 24 - 25
  • [45] Prognostic role of adding a genetic risk score to the new European SCORE2 in a cardiovascular events prediction, in a moderate-risk region
    Temtem, M.
    Palma Dos Reis, R.
    Serrao, M.
    Sa, D.
    Santos, M.
    Soares, C.
    Sousa, A. G.
    Rodrigues, M.
    Freitas, S.
    Henriques, E.
    Borges, S.
    Guerra, G.
    Ornelas, I.
    Drumond, A.
    Mendonca, M. I.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2273 - 2273
  • [46] Cardiovascular disease risk according to SCORE2 and the potential need for cholesterol and blood pressure lowering therapy in persons with HIV without established cardiovascular disease, Croatia
    Begovac, Josip
    Pintar, Vanja Romih
    Skugor, Sanja Belak
    Benkovic, Ivana
    Javoric, Ivana
    Zekan, Sime
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 263 - 264
  • [47] External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients
    Gynnild, M. N.
    Holtrop, J.
    Hageman, S.
    Vinje, V.
    Dorresteijn, J.
    Visseren, F.
    Holte, E.
    Dalen, H.
    Wethal, T.
    Omland, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [48] Cardiovascular disease risk assessment in HIV patients
    Haddon, L.
    Ryberg, A.
    HIV MEDICINE, 2010, 11 : 37 - 37
  • [49] Cardiovascular risk assessment using different equations:: Comparison of high risk prevalence in dyslipemic patients
    Fornasini, M
    Brotons, C
    Casanovas, J
    Iruela, A
    Vinyeta, R
    Martínez, M
    Bartés, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 118 - 118
  • [50] Agreement between the SCORE and D'Agostino Scales for the Classification of High Cardiovascular Risk in Sedentary Spanish Patients
    Gomez-Marcos, Manuel A.
    Grandes, Gonzalo
    Iglesias-Valiente, Jose A.
    Sanchez, Alvaro
    Montoya, Imanol
    Garcia-Ortiz, Luis
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2009, 6 (11): : 2800 - 2811
12345